Publications and Tools
National Guidelines
National Tuberculosis Coalition of America (NTCA) Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings
Clinical Infect Dis 2024
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
MMWR 2020; 69(RR-1): 1-11
Tuberculosis Screening Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019.
MMWR Weekly 2019; 68(19): 439–443
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
MMWR 2005; 54(RR-15): 1-37
Manuals and Implementation Guides
Testing and Treatment of Latent Tuberculosis Infection in the United States: A Clinical Guide for Health Care Providers and Public Health Programs, Third Edition
NTCA/National Society of TB Clinicians 2025
Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel: ACOEM and NTCA Joint Task Force on Implementation of the 2019 MMWR Recommendations
J Occup Environ Med 2020; 62(7): e355-e369
Tuberculosis Nursing Manual, Second Edition
NTCA/National TB Nurse Coalition 2011
Shorter Guidance
NTCA Provider Guidance: A 4-Month Regimen to Treat Pulmonary Tuberculosis: Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide (HPMZ)
NTCA 2022
NTCA Provider Guidance: Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)
NTCA 2018
NTCA/APHL Consensus Statement on the Use of Cepheid Xpert MTB/RIF Assay in Making Decisions to Discontinue Airborne Infection Isolation in Healthcare Settings
NTCA and Association of Public Health Laboratories 2016
Tools
Interjurisdictional Notification Form, Third Edition
Society for Epidemiology in TB Control and National TB Nurse Coalition 2024
TB Nurse Case Manager Core Competencies
National TB Nurse Coalition 2024